Rita Chiari
Impact in
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
- Oncology 111
- Cancer Immunotherapy and Biomarkers 44
- Lung Cancer Research Studies 24
- Colorectal Cancer Treatments and Studies 19
- HER2/EGFR in Cancer Research 10
- COVID-19 and healthcare impacts 9
-
- Lung Cancer Treatments and Mutations 87
- Lung Cancer Diagnosis and Treatment 19
- Co-authors
- Giulio Metro (53 shared papers)Biagio Ricciuti (41 shared papers)Lucio Crinò (38 shared papers)Vienna Ludovini (31 shared papers)Sara Baglivo (28 shared papers)Andrea De Giglio (16 shared papers)Guido Bellezza (24 shared papers)Marta Brambilla (10 shared papers)
- Journals
- Annals of Oncology (23 papers)Journal of Thoracic Oncology (21 papers)Lung Cancer (13 papers)Clinical Lung Cancer (11 papers)European Journal of Cancer (9 papers)
- Partner nations
- ItalyUnited StatesSpain
In The Last Decade
Rita Chiari
199 papers receiving 9.4k citations
Rita Chiari's Hit Papers
Peers
Comparison fields: 5 of 128
- Oncology 5.1k
- Pulmonary and Respiratory Medicine 4.5k
- Cancer Research 1.2k
- Biological Psychiatry 105
- Immunology 713
Countries citing papers authored by Rita Chiari
This map shows the geographic impact of Rita Chiari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rita Chiari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rita Chiari more than expected).
Fields of papers citing papers by Rita Chiari
This network shows the impact of papers produced by Rita Chiari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rita Chiari. The network helps show where Rita Chiari may publish in the future.
Co-authors
The 25 scholars most cited alongside Rita Chiari, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 210 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | First-line ceritinib versus platinum-based chemotherapy in advanced ALK -rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study Hit paper breakdown → | 2017 | 954 |
| 2 | Lorlatinib in patients with ALK-positive non-small-cell lung cancer: results from a global phase 2 study Hit paper breakdown → | 2018 | 649 |
| 3 | Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non–Small-Cell Lung Cancer Hit paper breakdown → | 2021 | 477 |
| 4 | 2019 | 337 | |
| 5 | 2019 | 316 | |
| 6 | Lorlatinib in advanced ROS1-positive non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 1–2 trial Hit paper breakdown → | 2019 | 300 |
| 7 | 2018 | 297 | |
| 8 | 2016 | 237 | |
| 9 | 2020 | 212 | |
| 10 | 2019 | 168 | |
| 11 | 2019 | 165 | |
| 12 | 2011 | 158 | |
| 13 | 2019 | 157 | |
| 14 | 2019 | 153 | |
| 15 | 2015 | 152 | |
| 16 | 2017 | 145 | |
| 17 | 2019 | 131 | |
| 18 | 2016 | 127 | |
| 19 | 2018 | 122 | |
| 20 | 2021 | 117 |
About Rita Chiari
Rita Chiari is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Biological Psychiatry, having authored 210 papers that have together received 9.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (87 papers), Cancer Immunotherapy and Biomarkers (44 papers), Lung Cancer Research Studies (24 papers), Colorectal Cancer Treatments and Studies (19 papers), Lung Cancer Diagnosis and Treatment (19 papers), HER2/EGFR in Cancer Research (10 papers), Cancer therapeutics and mechanisms (9 papers) and COVID-19 and healthcare impacts (9 papers). The work is most often cited by research in Oncology (5.1k citations), Pulmonary and Respiratory Medicine (4.5k citations), Cancer Research (1.2k citations), Biological Psychiatry (105 citations) and Immunology (713 citations). Rita Chiari has collaborated with scholars based in Italy, United States and Spain. Frequent co-authors include Giulio Metro, Biagio Ricciuti, Lucio Crinò, Vienna Ludovini, Sara Baglivo, Andrea De Giglio, Guido Bellezza, Marta Brambilla, Chiara Bennati and Pierre G. Coulie. Their work appears in journals such as Annals of Oncology, Journal of Thoracic Oncology, Lung Cancer, Clinical Lung Cancer and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.